← Back to Search

Behavioral Intervention

Behavioral Intervention for Lung Cancer (LuCA Trial)

N/A

Waitlist Available

Led By Rebecca A Shelby, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient Participants: 60 years of age or older

Patient Participants: Lung cancer diagnosis

Must not have

Visual or hearing impairment, cognitive impairment, or severe mental illness interfering with participation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to create a short assessment and behavioral intervention to help older adults with lung cancer manage their specific concerns related to aging. The study involves interviewing patients, caregivers, and healthcare providers to gather feedback

Who is the study for?

This trial is for older adults with lung cancer. It aims to help them manage symptoms and improve well-being by addressing aging-specific concerns. Participants will include patients, caregivers, and providers who can give feedback via teleconference interviews on the assessment and intervention materials.

What is being tested?

The LuCA Behavioral Intervention is being tested to see if it's helpful for older lung cancer patients in managing their symptoms related to aging. The study involves interviews to refine the program and a later phase where participants use the revised tools to check for improvements in mood and physical discomfort.

What are the potential side effects?

Since this trial focuses on behavioral interventions rather than medications, traditional side effects are not expected. However, discussing sensitive topics during interviews may cause emotional discomfort or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

Select...

I have been diagnosed with lung cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have any severe visual, hearing, cognitive impairments, or mental illnesses that would prevent me from participating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability as measured by Study Satisfaction Questionnaire

Feasibility as measured by number of participants who completed all study activities

Feasibility as measured by number of recruited participants who enrolled

Secondary study objectives

Change in anxiety symptoms as measured by the Generalized Anxiety Disorder (GAD-7) scale

Change in depressive symptoms as measured by the Patient Health Questionnaire (PHQ-9)

Change in dyspnea as measured by the Chronic Respiratory Questionnaire (CRQ)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Behavioral InterventionExperimental Treatment1 Intervention

Participants will engage in a 5-session protocol, to be delivered in an individual therapy setting, via telehealth or in-person. The program will integrate aspects of Cognitive Behavioral Therapy and Acceptance and Commitment Therapy.

0 / 3Eligibility criteria met